Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Beyond placebo purism: rebalancing evidence standards for digital therapeutics
1
Zitationen
2
Autoren
2026
Jahr
Abstract
Introduction Druart and Blease 1 raise an important question, especially in light of accelerated development of AI chatbots in digital medicine: what is the appropriate comparator in digital health trials?
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.557 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.447 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.944 Zit.
BioBERT: a pre-trained biomedical language representation model for biomedical text mining
2019 · 6.797 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.